Eneida R Nemecek

Eneida R Nemecek

UNVERIFIED PROFILE

Are you Eneida R Nemecek?   Register this Author

Register author
Eneida R Nemecek

Eneida R Nemecek

Publications by authors named "Eneida R Nemecek"

Are you Eneida R Nemecek?   Register this Author

30Publications

1004Reads

44Profile Views

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

N Engl J Med 2018 02;378(5):439-448

From the Departments of Pediatrics (S.L.M., S.A.G.) and Pathology and Laboratory Medicine (C.H.J., B.L.L.), Perelman School of Medicine, and Abramson Cancer Center (C.H.J., B.L.L.), University of Pennsylvania, and the Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia (S.L.M., S.A.G.) - all in Philadelphia; the Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, and the Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas (T.W.L.); the Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo (J.B.); the Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu Barcelona, Barcelona (S.R.); the Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City (M.B.); the Department of Pediatrics, Faculty of Medicine, University of Montreal, and the Hematology Oncology Division and Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal (H.B.), and the Division of Haematology/Oncology/Bone Marrow Transplantation, Hospital for Sick Children, Toronto (J.K.) - all in Canada; the Division of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany (P.B.); the Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis (M.R.V., H.E.S.); Children's Mercy Hospital and Clinics, Kansas City, MO (G.D.M.); Aflac Cancer and Blood Disorders Center, Emory University, Atlanta (M.Q.); the Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, and the Cancer Research Institute Ghent (CRIG), Ghent, Belgium (B.D.M.); the Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto, Japan (H.H.); the Department of Pediatrics, Stanford University School of Medicine, Stanford (K. Schlis, K.L.D.), and the Division of Hematology, Oncology, Blood and Marrow Transplant, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles (M.A.P.) - all in California; the Division of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, NC (P.L.M.); Oregon Health and Science University, Portland (E.R.N.); C.S. Mott Children's Hospital, Ann Arbor, MI (G.A.Y.); the Stem Cell Transplantation Unit, St. Anna Children's Hospital, Vienna (C.P.); University Hospital Robert Debré and University Paris Diderot (A. Baruchel), and Saint-Louis Hospital and University Paris Diderot (N.B.), Paris; the Royal Children's Hospital, Melbourne, VIC, Australia (F.M.); Clinica Pediatrica Universita degli Studi di Milano Bicocca, Monza, Italy (A. Balduzzi); and Novartis Pharmaceuticals (P.W., T.T., M.L., Y.Z., K. Sen, D.L.) and Novartis Institutes for Biomedical Research (K.T.M.) - both in East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996391PMC
February 2018

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.

Biol Blood Marrow Transplant 2017 Oct 7;23(10):1669-1677. Epub 2017 Jun 7.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington; Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Hematology-Oncology, Seattle Children's Hospital, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605451PMC
October 2017

Marrow harvesting: practice makes perfect.

Authors:
Eneida R Nemecek

Transfusion 2016 05;56(5):1005

Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.13597DOI Listing
May 2016

Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.

Biol Blood Marrow Transplant 2014 Dec 6;20(12):1996-2003. Epub 2014 Sep 6.

Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington; Seattle Children's Hospital, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.08.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324724PMC
December 2014

Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia.

Pediatr Blood Cancer 2013 Mar 18;60(3):455-60. Epub 2012 Jul 18.

Departments of Pediatrics and Cell & Developmental Biology, Papé Family Pediatric Research Institute, Oregon Stem Cell Center, Oregon Health & Science University, Portland, Oregon 97239, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.24247
Publisher Site
http://dx.doi.org/10.1002/pbc.24247DOI Listing
March 2013

Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults.

Antimicrob Agents Chemother 2011 Dec 12;55(12):5780-9. Epub 2011 Sep 12.

Department of Pediatrics and Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.05010-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232803PMC
December 2011

Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model.

Clin Cancer Res 2005 Jan;11(2 Pt 1):787-94

Division of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Fairview Avenue North, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
January 2005

Use of radiolabeled antibodies in the treatment of childhood acute leukemia.

Pediatr Transplant 2003 ;7 Suppl 3:89-94

Divisions of Clinical Research and Pediatric Hematology/Oncology, Fred Hutchinson Cancer Research Center and University of Washington, PO Box 19024, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
July 2003

Treatment of neuroblastoma in patients with neurocristopathy syndromes.

J Pediatr Hematol Oncol 2003 Feb;25(2):159-62

Pediatric Hematology/Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200302000-00015DOI Listing
February 2003

Antibody-based therapy of human leukemia.

Curr Opin Hematol 2002 Jul;9(4):316-21

Pediatric Hematology/Oncology Fellow, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
July 2002